Home > Products > EGFR & HER2
> Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (scIgG)
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (scIgG) (CAT#: SCIGG-155)
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-EGFR and anti-HER2 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Breast cancer; Colon cancer; Lung cancer; Pancreatic cancer; Gastric cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (scIgG) (SCIGG-155). Click the button below to contact us or submit your feedback about this product.